{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T05:38:48Z","timestamp":1791610728255,"version":"4.3.4"},"reference-count":56,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T00:00:00Z","timestamp":1722297600000},"content-version":"unspecified","delay-in-days":29,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill & Melinda Gates Foundation","doi-asserted-by":"crossref","award":["INV-007610"],"award-info":[{"award-number":["INV-007610"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["bmjph"],"accepted":{"date-parts":[[2024,7,2]]},"published-print":{"date-parts":[[2024,7]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>There is lack of available data on the economic burden of wheezing episodes after severe respiratory syncytial virus (RSV) infection. This study aimed to assess the cost incurred for wheezing episodes after a severe RSV infection in children from Argentina, considering both the public health system and societal perspectives.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A prospective cohort was conducted from 2014 to 2022 to assess the cost of illness of wheezing episodes after severe RSV disease in children from Buenos Aires, Argentina. Direct medical and non-medical costs were estimated, along with indirect costs per episode and patient. Data pertaining to healthcare resource utilisation, indirect expenses and parental out-of-pocket costs were obtained. The overall cost per hospitalisation and health visits was calculated. Costs were quantified in US dollars using the average exchange rate on the specific date of data collection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 256 infants experienced severe RSV disease during their first year of life and were followed over a 5-year period in Buenos Aires. Overall, 150 children between 12 and 60 months presented 429 wheezing episodes. The median number of wheezing episodes per patient was 5 (IQR 3\u20137). The mean cost per wheezing episode was US$191.01 (95% CI 166.37 to 215.64). The total cost per episode of wheezing was significantly higher (p&lt;0.001) in infants under 12 months of age (207.43, 95% CI 154.3 to 260.6) compared with older toddler. The average cumulative cost associated to wheezing per patient was US$415.99 (95% CI 313.35 to 518.63). Considering both acute RSV disease and long-term wheezing outcomes, the cumulative mean cost per patient was US$959.56 (95% CI 832.01 to 1087.10).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study reveals the economic impact of prolonged wheezing resulting from severe acute RSV infection on Argentina\u2019s public health system and society. The estimates obtained serve as valuable inputs for informing cost-effectiveness analyses of upcoming RSV preventive interventions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjph-2024-000975","type":"journal-article","created":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T08:21:08Z","timestamp":1722414068000},"page":"e000975","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Assessing the long-term economic impact of wheezing episodes after severe RSV disease in children from Argentina: a cost of illness analysis"],"prefix":"10.1136","volume":"2","author":[{"given":"Julia","family":"Dvorkin","sequence":"first","affiliation":[{"name":"Fundaci\u00f3n Infant, Buenos Aires, Argentina"},{"name":"Escuela de Bio y Nanotecnolog\u00eda, Universidad Nacional de San Martin Buenos Aires, Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), Buenos Aires, Buenos Aires, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clint","family":"Pecenka","sequence":"additional","affiliation":[{"name":"Center for Vaccine Innovation and Access, PATH, Seattle, Washington, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emiliano M","family":"Sosa","sequence":"additional","affiliation":[{"name":"Fundaci\u00f3n Infant, Buenos Aires, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Sancilio","sequence":"additional","affiliation":[{"name":"Fundaci\u00f3n Infant, Buenos Aires, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina","family":"Due\u00f1as","sequence":"additional","affiliation":[{"name":"Fundaci\u00f3n Infant, Buenos Aires, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Rodriguez","sequence":"additional","affiliation":[{"name":"Fundaci\u00f3n Infant, Buenos Aires, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Rojas-Roque","sequence":"additional","affiliation":[{"name":"Centre for Health Economics, University of York, York, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia B","family":"Carruitero","sequence":"additional","affiliation":[{"name":"Facultad de Ciencias Econ\u00f3micas, Universidad Nacional de la Plata, La Plata, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranju","family":"Baral","sequence":"additional","affiliation":[{"name":"Center for Vaccine Innovation and Access, PATH, Seattle, Washington, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Vodicka","sequence":"additional","affiliation":[{"name":"Center for Vaccine Innovation and Access, PATH, Seattle, Washington, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando P","family":"Polack","sequence":"additional","affiliation":[{"name":"Fundaci\u00f3n Infant, Buenos Aires, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romina","family":"Libster","sequence":"additional","affiliation":[{"name":"Fundaci\u00f3n Infant, Buenos Aires, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4218-5942","authenticated-orcid":false,"given":"Mauricio T","family":"Caballero","sequence":"additional","affiliation":[{"name":"Fundaci\u00f3n Infant, Buenos Aires, Argentina"},{"name":"Escuela de Bio y Nanotecnolog\u00eda, Universidad Nacional de San Martin Buenos Aires, Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), Buenos Aires, Buenos Aires, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,7,31]]},"reference":[{"key":"2025083109361406000_2.1.e000975.1","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(22)00478-0"},{"key":"2025083109361406000_2.1.e000975.2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)30938-8"},{"key":"2025083109361406000_2.1.e000975.3","doi-asserted-by":"crossref","first-page":"S229","DOI":"10.1093\/cid\/ciab528","article-title":"Global respiratory syncytial virus\u2013related infant community deaths","volume":"73","author":"Mazur","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2025083109361406000_2.1.e000975.4","doi-asserted-by":"crossref","first-page":"595","DOI":"10.2147\/IDR.S373584","article-title":"Responding to higher-than-expected infant mortality rates from respiratory syncytial virus (RSV): improving treatment and reporting strategies","volume":"16","author":"Dvorkin","year":"2023","journal-title":"Infect Drug Resist"},{"key":"2025083109361406000_2.1.e000975.5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60206-1"},{"key":"2025083109361406000_2.1.e000975.6","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201603-0658OC"},{"key":"2025083109361406000_2.1.e000975.7","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1164\/rccm.201301-0016OC","article-title":"Macronutrients during pregnancy and life-threatening respiratory syncytial virus infections in children","volume":"187","author":"Ferolla","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"2025083109361406000_2.1.e000975.8","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiy517"},{"key":"2025083109361406000_2.1.e000975.9","doi-asserted-by":"crossref","first-page":"S210","DOI":"10.1093\/cid\/ciab497","article-title":"Community mortality due to respiratory syncytial virus in Argentina: population-based surveillance study","volume":"73","author":"Caballero","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2025083109361406000_2.1.e000975.10","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)10321-5"},{"key":"2025083109361406000_2.1.e000975.11","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1016\/S0140-6736(23)00811-5","article-title":"Respiratory syncytial virus infection during infancy and asthma during childhood in the USA (INSPIRE): a population-based, prospective birth cohort study","volume":"401","author":"Rosas-Salazar","year":"2023","journal-title":"Lancet"},{"key":"2025083109361406000_2.1.e000975.12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1211917"},{"key":"2025083109361406000_2.1.e000975.13","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1097\/INF.0000000000001167","article-title":"The impact of respiratory syncytial virus disease prevention on pediatric asthma","volume":"35","author":"Caballero","year":"2016","journal-title":"Pediatr Infect Dis J"},{"key":"2025083109361406000_2.1.e000975.14","doi-asserted-by":"crossref","first-page":"S628","DOI":"10.1093\/infdis\/jiz311","article-title":"Association between respiratory syncytial virus-associated acute lower respiratory infection in early life and recurrent wheeze and asthma in later childhood","volume":"222","author":"Shi","year":"2020","journal-title":"J Infect Dis"},{"key":"2025083109361406000_2.1.e000975.15","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2013-0982"},{"key":"2025083109361406000_2.1.e000975.16","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1164\/rccm.202009-3696OC","article-title":"Recurrent severe preschool wheeze: from prespecified diagnostic labels to underlying endotypes","volume":"204","author":"Robinson","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"2025083109361406000_2.1.e000975.17","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00199913"},{"key":"2025083109361406000_2.1.e000975.18","doi-asserted-by":"crossref","first-page":"673","DOI":"10.24953\/turkjped.2021.04.015","article-title":"Cost of illness of RSV infection in a middle-income tropical country","volume":"63","author":"Buend\u00eda","year":"2021","journal-title":"Turk J Pediatr"},{"key":"2025083109361406000_2.1.e000975.19","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-046563","article-title":"Impact and cost-effectiveness of potential interventions against infant respiratory syncytial virus (RSV) in 131 low-income and middle-income countries using a static cohort model","volume":"11","author":"Baral","year":"2021","journal-title":"BMJ Open"},{"key":"2025083109361406000_2.1.e000975.20","first-page":"S318","article-title":"Discussing the COSTS of asthma: controlling outcomes, symptoms, and treatment strategies","volume":"11","author":"Bukstein","year":"2005","journal-title":"Am J Manag Care"},{"key":"2025083109361406000_2.1.e000975.21","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/ppe.12295","article-title":"Population-attributable risk of risk factors for recurrent wheezing in moderate preterm infants during the first year of life","volume":"30","author":"Blanken","year":"2016","journal-title":"Paediatr Perinat Epidemiol"},{"key":"2025083109361406000_2.1.e000975.22","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2010.542744"},{"key":"2025083109361406000_2.1.e000975.23","doi-asserted-by":"publisher","DOI":"10.1093\/jpids\/piaa157"},{"key":"2025083109361406000_2.1.e000975.24","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-023-08024-2","article-title":"Estimating the economic burden of respiratory syncytial virus infections in infants in Vietnam: a cohort study","volume":"23","author":"Do","year":"2023","journal-title":"BMC Infect Dis"},{"key":"2025083109361406000_2.1.e000975.25","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-015-1213-4","article-title":"Incidence of viral respiratory infections in a prospective cohort of outpatient and hospitalized children aged \u22645 years and its associated cost in Buenos Aires, Argentina","volume":"15","author":"Marcone","year":"2015","journal-title":"BMC Infect Dis"},{"key":"2025083109361406000_2.1.e000975.26","doi-asserted-by":"crossref","DOI":"10.1186\/s12889-024-17878-3","article-title":"Cost of illness due to respiratory syncytial virus acute lower respiratory tract infection among infants hospitalized in Argentina","volume":"24","author":"Dvorkin","year":"2024","journal-title":"BMC Public Health"},{"key":"2025083109361406000_2.1.e000975.27","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S2213-2600(17)30303-X","article-title":"Determining the outcomes of interventions to prevent respiratory syncytial virus disease in children: what to measure?","volume":"6","author":"Karron","year":"2018","journal-title":"Lancet Respir Med"},{"key":"2025083109361406000_2.1.e000975.28","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiz278"},{"key":"2025083109361406000_2.1.e000975.29","doi-asserted-by":"publisher","DOI":"10.3350\/cmh.2014.20.4.327"},{"key":"2025083109361406000_2.1.e000975.30","doi-asserted-by":"publisher","DOI":"10.2165\/11588380-000000000-00000"},{"key":"2025083109361406000_2.1.e000975.31","doi-asserted-by":"crossref","first-page":"S111","DOI":"10.1093\/cid\/ciaa481","article-title":"Methodological considerations for cost of illness studies of enteric fever","volume":"71","author":"Mejia","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2025083109361406000_2.1.e000975.32","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1080\/23288604.2018.1477537","article-title":"Making universal health care effective in Argentina: a blueprint for reform","volume":"4","author":"Rubinstein","year":"2018","journal-title":"Health Syst Reform"},{"key":"2025083109361406000_2.1.e000975.33","first-page":"73","article-title":"Renewing primary health care in the Americas","volume":"21","author":"Macinko","year":"2007","journal-title":"Rev Panam Salud Publica"},{"key":"2025083109361406000_2.1.e000975.34","unstructured":"Tipo de cobertura de salud de la poblaci\u00f3n (en porcentaje). Available: https:\/\/www.estadisticaciudad.gob.ar\/si\/genero\/principal-indicador?indicador=tip_cob_sal [Accessed 22 Aug 2022]."},{"key":"2025083109361406000_2.1.e000975.35","doi-asserted-by":"crossref","DOI":"10.1186\/s12939-020-01292-3","article-title":"Building a sanitary vulnerability map from open source data in Argentina (2010-2018)","volume":"19","author":"Rosati","year":"2020","journal-title":"Int J Equity Health"},{"key":"2025083109361406000_2.1.e000975.36","unstructured":"Redatam . National census of population, households and housing 2010 of Argentina. Available: https:\/\/redatam.indec.gob.ar\/argbin\/RpWebEngine.exe\/PortalAction?BASE=CPV2010B [Accessed 4 Apr 2024]."},{"key":"2025083109361406000_2.1.e000975.37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2008.08.010"},{"key":"2025083109361406000_2.1.e000975.38","doi-asserted-by":"crossref","unstructured":"Dvorkin J , Sosa E , Vodicka E , et al . Cost of illness due to respiratory syncytial virus acute lower respiratory tract infection among infants hospitalized in Argentina. In Review [Preprint] 2023. doi:10.21203\/rs.3.rs-3386023\/v1","DOI":"10.21203\/rs.3.rs-3386023\/v1"},{"key":"2025083109361406000_2.1.e000975.39","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1908380"},{"key":"2025083109361406000_2.1.e000975.40","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiw447"},{"key":"2025083109361406000_2.1.e000975.41","doi-asserted-by":"publisher","DOI":"10.1111\/cea.13325"},{"key":"2025083109361406000_2.1.e000975.42","unstructured":"Tipos de Cambio. Available: https:\/\/www.bcra.gob.ar\/PublicacionesEstadisticas\/Tipos_de_cambios.asp [Accessed 9 Jun 2023]."},{"key":"2025083109361406000_2.1.e000975.43","first-page":"197","article-title":"Acute effect of nebulized budesonide in asthmatic children","volume":"15","author":"Nuhoglu","year":"2005","journal-title":"J Investig Allergol Clin Immunol"},{"key":"2025083109361406000_2.1.e000975.44","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.anai.2010.10.009","article-title":"The pulmonary index score as a clinical assessment tool for acute childhood asthma","volume":"105","author":"Hsu","year":"2010","journal-title":"Ann Allergy Asthma Immunol"},{"key":"2025083109361406000_2.1.e000975.45","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-6296(98)00030-7"},{"key":"2025083109361406000_2.1.e000975.46","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1524-4733.2007.00228.x","article-title":"Estimating the cost of complications of diabetes in Australia using administrative health-care data","volume":"11","author":"Clarke","year":"2008","journal-title":"Value Health"},{"key":"2025083109361406000_2.1.e000975.47","doi-asserted-by":"publisher","DOI":"10.1258\/1355819042250249"},{"key":"2025083109361406000_2.1.e000975.48","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s40273-019-00771-y","article-title":"An educational review about using cost data for the purpose of cost-effectiveness analysis","volume":"37","author":"Franklin","year":"2019","journal-title":"Pharmacoeconomics"},{"key":"2025083109361406000_2.1.e000975.49","unstructured":"Griffiths U , Rheingans R , Walker D . Guidelines for estimating the economic burden of diarrhoeal disease with focus on assessing the impact of rotavirus diarrhoea. Geneva, Switzerland: World Health Organization, 2005. Available: https:\/\/extranet.who.int\/libdoc.html?ua=1"},{"key":"2025083109361406000_2.1.e000975.50","unstructured":"administrador . Incidencia de la pobreza en personas. Observatorio del Conurbano Bonaerense. 2020. Available: http:\/\/observatorioconurbano.ungs.edu.ar\/?p=12826 [Accessed 26 Aug 2021]."},{"key":"2025083109361406000_2.1.e000975.51","doi-asserted-by":"crossref","first-page":"699","DOI":"10.2147\/CEOR.S382495","article-title":"The long-term healthcare utilization and economic burden of RSV infection in children \u22645 years in Japan: propensity score matched cohort study","volume":"14","author":"Chirikov","year":"2022","journal-title":"Clinicoecon Outcomes Res"},{"key":"2025083109361406000_2.1.e000975.52","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1016\/j.vaccine.2014.01.080","article-title":"National immunization commission: strengthening evidence-based decision making in Argentina","volume":"32","author":"Stecher","year":"2014","journal-title":"Vaccine (Auckl)"},{"key":"2025083109361406000_2.1.e000975.53","first-page":"84","article-title":"[Recommendations for palivizumab use. Update 2015]","volume":"114","author":"Fern\u00e1ndez Jonusas","year":"2016","journal-title":"Arch Argent Pediatr"},{"key":"2025083109361406000_2.1.e000975.54","unstructured":"Manuel L , Puente De la . AN\u00e1LISIS DEL COMPORTAMIENTO DEL MERCADO DE MEDICAMENTOS Y POSICIONAMIENTO DEL PROGRAMA REMEDIAR [informe final]. In: Programa de Fortalecimiento de la Estrategia de Atenci\u00f3n Primaria de la Salud Programa REMEDIAR \u00c1REA de Monitoreo y Evaluaci\u00f3n. 2013. Available: http:\/\/186.33.221.24\/medicamentos\/\/files\/Analisis_del_Comportamiento_del_Mercado_de_Medicamentos.pdf"},{"key":"2025083109361406000_2.1.e000975.55","doi-asserted-by":"crossref","first-page":"e318","DOI":"10.1016\/S1473-3099(23)00568-6","article-title":"The full value of immunisation against respiratory syncytial virus for infants younger than 1 year: effects beyond prevention of acute respiratory illness","volume":"24","author":"Feikin","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"2025083109361406000_2.1.e000975.56","unstructured":"BOLETIN OFICIAL REPUBLICA ARGENTINA - MINISTERIO DE SALUD . Resoluci\u00f3n 4218\/2023. Available: https:\/\/www.boletinoficial.gob.ar\/detalleAviso\/primera\/300984 [Accessed 30 Dec 2023]."}],"container-title":["BMJ Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjph-2024-000975","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T16:36:32Z","timestamp":1756658192000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjpublichealth.bmj.com\/lookup\/doi\/10.1136\/bmjph-2024-000975"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,7,31]]},"published-print":{"date-parts":[[2024,7]]}},"alternative-id":["10.1136\/bmjph-2024-000975"],"URL":"https:\/\/doi.org\/10.1136\/bmjph-2024-000975","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.03.18.24304483","asserted-by":"object"}]},"ISSN":["2753-4294"],"issn-type":[{"value":"2753-4294","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7]]}}}